The Federal Reserve announced that it has reduced Morgan Stanley’s (MS) Stress Capital Buffer, or SCB, from 5.1% to 4.3%, effective on October 1, in response to the firm seeking reconsideration of its preliminary SCB announced in June 2025. Together with other features of the regulatory capital framework, this SCB results in an aggregate U.S. Basel III Standardized Approach Common Equity Tier 1 ratio of 11.8%. The Firm’s U.S. Basel III Standardized Approach CET1 ratio was 15.0% as of June 30, 2025. Sharon Yeshaya, executive VP and CFO of Morgan Stanley, said: “Morgan Stanley appreciates the Federal Reserve’s careful reconsideration of our 2025 CCAR results. We look forward to continued constructive engagement with the Federal Reserve on the stress testing framework. Morgan Stanley remains focused on ensuring we have long-term capacity to support global client engagement, invest in our core businesses and consistently grow our quarterly dividend.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MS:
- Morgan Stanley price target raised to $165 from $150 at Evercore ISI
- Upcoming IPO Alert! Beta Technologies and Ethos Gear Up for U.S. Market Debuts
- Crypto Currents: SEC clears path for altcoin ETFs as SWIFT plans blockchain
- Crypto Currents: Strive, Semler Scientific announce bitcoin treasury merger
- Morgan Stanley price target raised to $155 from $130 at Citi
